Table 4 Statistics of drug-target number in the HCDT database.
From: Integrative genomics characterizes HCC eRNAs for prognosis and targeted therapy
Drug name | Target number |
|---|---|
Imatinib | 157 |
Sorafenib | 184 |
Bevacizumab | 86 |
Lenvatinib | 33 |
Cabozantinib | 23 |
Nivolumab | 7 |
Atezolizumab | 5 |
